Abstract
In patients with extremely poor ovarian response (1–2 oocytes retrieved), the use of Intracytoplasmic Sperm Injection (ICSI) is often employed as a safeguard against total fertilization failure (TFF). However, this large-scale retrospective study demonstrates that ICSI does not prevent TFF in these cases and may actually hamper cumulative pregnancy rates compared to conventional IVF.
Introduction
In assisted reproductive technology (ART), clinicians face a high-pressure dilemma when a patient yields only one or two oocytes. If these fail to fertilize—a condition known as Total Fertilization Failure (TFF)—the entire treatment cycle is lost. To mitigate this risk, many clinics default to ICSI, where a single sperm is manually injected into the egg. While ICSI is essential for severe male-factor infertility, its routine use for non-male factors is often driven by an "irrational fear" of TFF rather than clinical evidence. This study investigates whether ICSI provides a genuine benefit for "extremely poor responders" or if the invasive nature of the procedure inadvertently harms their limited chances of success.
Methodology
The researchers conducted a retrospective study of 2,572 patients treated between 2013 and 2022 at the Reproductive Medicine Center of Xiamen University Affiliated Chenggong Hospital. Inclusion criteria focused on patients with 1–2 oocytes retrieved and non-severe male factor infertility (Total Motile Sperm Count > 2 × 10⁶).
To ensure a fair comparison between the IVF group (2,159 patients) and the ICSI group (413 patients), the study employed Propensity Score (PS) Matching. This statistical technique created two balanced cohorts of 401 patients each, matched across 18 variables including maternal age, BMI, sperm quality, and ovarian stimulation protocols.
Key Results
Fertilization and Pregnancy Outcomes
Contrary to clinical intuition, ICSI did not serve as an effective safety net. The ICSI group exhibited a significantly higher rate of TFF (14.0%) compared to the matched IVF group (7.7%). Multivariate regression analysis confirmed that ICSI was associated with a 65% higher risk of TFF (Adjusted OR: 1.65; 95% CI: 1.12–2.43).
Furthermore, patients undergoing traditional IVF achieved a significantly higher cumulative pregnancy rate per initiated cycle (28.7%) compared to those receiving ICSI (21.7%). The odds of achieving a clinical pregnancy were 35% lower in the ICSI group (Adjusted OR: 0.65; 95% CI: 0.46–0.91).
Embryo Quality and Live Births
Interestingly, once fertilization was successful, the quality of the resulting embryos was comparable between both groups. This suggests that the negative impact of ICSI is primarily concentrated at the fertilization stage. While the IVF group showed a higher absolute cumulative live birth rate (21.2% vs. 17.2%), this difference did not reach statistical significance (P=0.179), likely due to the limited sample size of successful births in this challenging population.
Discussion
The study suggests several reasons for these counter-intuitive findings:
- Maturation Asynchrony: ICSI requires early "denudation" (removing protective cumulus cells). In IVF, the egg remains in its natural microenvironment longer, potentially allowing for better nucleus-cytoplasmic maturation.
- Bypassing Natural Selection: ICSI bypasses the natural selection barriers of the oocyte's outer layers. For poor responders, oocyte quality is the primary bottleneck, and forced fertilization cannot overcome inherent deficiencies.
Conclusion and Future Directions
For patients with extremely poor ovarian response and non-severe male factor infertility, conventional IVF appears superior to ICSI. The study highlights that the invasive nature of ICSI may be counterproductive in these high-stakes cases. Future research should explore less invasive "add-ons," such as microfluidic sperm sorting, and prioritize randomized controlled trials to confirm these findings. Clinicians are encouraged to reconsider the routine use of ICSI as a "safety net" for poor responders.
Summary updated